Inventor · disambiguated record
Arash Ash Alizadeh
Also filed as: ALIZADEH ARASH · ALIZADEH ARASH A · ALIZADEH ARASH ASH
18 granted patents·28 pending applications·183 citations·filing 2010–2025
94Inventor score
Files withUNIV LELAND STANFORD JUNIOR38ALIZADEH ARASH ASH3KOHRT HOLBROOK1PREDICTIVEIQ LLC1THE BOARD OF TRUSTEES OF THE LEIAND STANFORD JUNIOR UNIV1
Top patents by PatentIndex Score
46 records- 0196US11447833B2Methods for preparing nucleic acid libraries for sequencingUNIV LELAND STANFORD JUNIOR·Filed 2021·Granted Sep 20, 2022·7 cites·30 claims
- 0296US8758750B2Synergistic anti-CD47 therapy for hematologic cancersWEISSMAN IRVING L·Filed 2010·Granted Jun 24, 2014·50 cites·8 claims
- 0395US11634779B2Methods and systems for analyzing nucleic acid moleculesUNIV LELAND STANFORD JUNIOR·Filed 2022·Granted Apr 25, 2023·6 cites·14 claims
- 0495US11613787B2Methods and systems for analyzing nucleic acid moleculesUNIV LELAND STANFORD JUNIOR·Filed 2021·Granted Mar 28, 2023·4 cites·30 claims
- 0594US11965215B2Methods and systems for analyzing nucleic acid moleculesUNIV LELAND STANFORD JUNIOR·Filed 2023·Granted Apr 23, 2024·1 cites·24 claims
- 0694US11851716B2Methods and systems for analyzing nucleic acid moleculesUNIV LELAND STANFORD JUNIOR·Filed 2022·Granted Dec 26, 2023·1 cites·23 claims
- 0793US11802314B2Methods and systems for determining proportions of distinct cell subsetsUNIV LELAND STANFORD JUNIOR·Filed 2018·Granted Oct 31, 2023·12 cites·33 claims
- 0893US10167514B2Methods and systems for determining proportions of distinct cell subsetsUNIV LELAND STANFORD JUNIOR·Filed 2016·Granted Jan 1, 2019·14 cites·18 claims
- 0993US9758589B2Methods for enhancing anti-tumor antibody therapyUNIV LELAND STANFORD JUNIOR·Filed 2014·Granted Sep 12, 2017·25 cites·36 claims
- 1092US12031183B2Methods and systems for determining proportions of distinct cell subsetsUNIV LELAND STANFORD JUNIOR·Filed 2018·Granted Jul 9, 2024·9 cites·23 claims
- 1190US11783912B2Methods and systems for analyzing nucleic acid moleculesUNIV LELAND STANFORD JUNIOR·Filed 2022·Granted Oct 10, 2023·2 cites·30 claims
- 1290US9005619B2Methods for enhancing anti-tumor antibody therapyKOHRT HOLBROOK·Filed 2010·Granted Apr 14, 2015·39 cites·37 claims
- 1389US12249401B2Systems and methods for analyzing mixed cell populationsUNIV LELAND STANFORD JUNIOR·Filed 2018·Granted Mar 11, 2025·7 cites·19 claims
- 1489US2024175088A1Methods and Systems for Analyzing Nucleic Acid MoleculesUNIV LELAND STANFORD JUNIOR·Filed 2024·Application pending·0 cites
- 1588US10633450B2Methods for enhancing anti-tumor antibody therapyUNIV LELAND STANFORD JUNIOR·Filed 2017·Granted Apr 28, 2020·3 cites·17 claims
- 1688US2024035095A1Methods and Systems for Analyzing Nucleic Acid MoleculesUNIV LELAND STANFORD JUNIOR·Filed 2023·Application pending·0 cites
- 1788US2025129425A1Methods and Systems for Determining Proportions of Distinct Cell SubsetsUNIV LELAND STANFORD JUNIOR·Filed 2024·Application pending·0 cites
- 1887US12421559B2Identification and use of circulating nucleic acid tumor markersUNIV LELAND STANFORD JUNIOR·Filed 2024·Granted Sep 23, 2025·0 cites·19 claims
- 1985US2023183816A1Methods and Systems for Analyzing Nucleic Acid MoleculesUNIV LELAND STANFORD JUNIOR·Filed 2023·Application pending·0 cites
- 2084US11085084B2Identification and use of circulating nucleic acidsUNIV LELAND STANFORD JUNIOR·Filed 2015·Granted Aug 10, 2021·3 cites·1 claims
- 2184US2025346960A1Identification and use of circulating nucleic acid tumor markersUNIV LELAND STANFORD JUNIOR·Filed 2025·Application pending·0 cites
- 2284US2025340951A1Identification and use of circulating nucleic acid tumor markersUNIV LELAND STANFORD JUNIOR·Filed 2025·Application pending·0 cites
- 2383US2022389518A1Methods and Systems for Analyzing Nucleic Acid MoleculesUNIV LELAND STANFORD JUNIOR·Filed 2022·Application pending·0 cites
- 2478US12492434B2Methods and systems for analyzing nucleic acid moleculesUNIV LELAND STANFORD JUNIOR·Filed 2021·Granted Dec 9, 2025·0 cites·30 claims
- 2576US2021172022A1Methods and Systems for Analyzing Nucleic Acid MoleculesUNIV LELAND STANFORD JUNIOR·Filed 2020·Application pending·0 cites
- 2676US2014296081A1Identification and use of circulating tumor markersUNIV LELAND STANFORD JUNIOR·Filed 2014·Application pending·0 cites
- 2775US2024105281A1Methods and Systems for Analyzing Nucleic Acid MoleculesUNIV LELAND STANFORD JUNIOR·Filed 2023·Application pending·0 cites
- 2874US2022195530A1Identification and use of circulating nucleic acid tumor markersUNIV LELAND STANFORD JUNIOR·Filed 2021·Application pending·0 cites
- 2971US2021214437A1Synergistic anti-cd47 therapy for hematologic cancersUNIV LELAND STANFORD JUNIOR·Filed 2021·Application pending·0 cites
- 3069US2016032396A1Identification and Use of Circulating Nucleic Acid Tumor MarkersUNIV LELAND STANFORD JUNIOR·Filed 2014·Application pending·0 cites
- 3161US2014369924A1Synergistic anti-cd47 therapy for hematologic cancersUNIV LELAND STANFORD JUNIOR·Filed 2014·Application pending·0 cites
- 3260US2024161868A1System and method for gene expression and tissue of origin inference from cell-free dnaTHE BOARD OF TRUSTEES OF THE LEIAND STANFORD JUNIOR UNIV·Filed 2022·Application pending·0 cites
- 3360US2019048075A1Synergistic anti-cd47 therapy for hematologic cancersUNIV LELAND STANFORD JUNIOR·Filed 2018·Application pending·0 cites
- 3457US2025263789A1Methods of Analyzing Cell Free Nucleic Acids and Applications ThereofUNIV LELAND STANFORD JUNIOR·Filed 2022·Application pending·0 cites
- 3557US2023242980A1Systems and Methods for Protecting Nucleic Acid MoleculesUNIV LELAND STANFORD JUNIOR·Filed 2022·Application pending·0 cites
- 3656US2023383361A1Methods to predict outcomes to chimeric antigen receptor t-cells in lymphoma from cell-free dna and genetic mutationsUNIV LELAND STANFORD JUNIOR·Filed 2021·Application pending·0 cites
- 3754US2021363597A1Identification and use of circulating nucleic acidsUNIV LELAND STANFORD JUNIOR·Filed 2021·Application pending·0 cites
- 3853US2022392605A1Methods to Assess Clinical Outcome Based Upon Updated Probabilities and Treatments ThereofTHE BOARD OF TRUSTES OF THE LELAND STANFORD JUNIOR UNIV·Filed 2021·Application pending·0 cites
- 3951US2025281532A1Methods for diagnosing or treating health conditions or optimizing therapeutic efficacy of car-t cells therapiesUNIV LELAND STANFORD JUNIOR·Filed 2021·Application pending·0 cites
- 4050US2021033608A1Methods and Systems for Identification of Human Leukocyte Antigen Peptide Presentation and Applications ThereofUNIV LELAND STANFORD JUNIOR·Filed 2020·Application pending·0 cites
- 4149US2025299104A1Apparatus and methods for advanced diagnostics and prognostics of systems based on physics informed machine learning processesPREDICTIVEIQ LLC·Filed 2025·Application pending·0 cites
- 4247US2023027353A1Systems and Methods for Deconvoluting Tumor Ecosystems for Personalized Cancer TherapyUNIV LELAND STANFORD JUNIOR·Filed 2020·Application pending·0 cites
- 4343US9605320B2Method of predicting responsiveness of B cell lineage malignancies to active immunotherapyALIZADEH ARASH ASH·Filed 2012·Granted Mar 28, 2017·0 cites·4 claims
- 4434US2014148351A1Prediction of Clinical Outcome in Hematological Malignancies Using a Self-Renewal Expression SignatureALIZADEH ARASH ASH·Filed 2011·Application pending·0 cites
- 4533US2017073763A1Methods and Compositions for Assessing Patients with Non-small Cell Lung CancerUNIV LELAND STANFORD JUNIOR·Filed 2015·Application pending·0 cites
- 4631US2012134986A1Methods of Prognosis for Non-Hodgkin LymphomaALIZADEH ARASH ASH·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Arash Ash Alizadeh files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →